Argentarii’s Boston Scientific BSX Stock Holding History

Argentarii’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Sell	25,022 -3,631	-13%	-$290K	0.55%	38
2025 Q4	$2.73M	Sell	28,653 -160	-0.6%	-$15.7K	0.89%	24
2025 Q3	$2.81M	Buy	28,813 +5	+0%	+$518	1.12%	21
2025 Q2	$3.09M	Sell	28,808 -2,175	-7%	-$220K	1.42%	18
2025 Q1	$3.13M	Buy	30,983 +3,616	+13%	+$364K	1.55%	17
2024 Q4	$2.44M	Buy	+27,367	New	+$2.41M	1.23%	18

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Argentarii's BSX Position: Q1 2026 in Review

Argentarii reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $290K and leaving 25,022 shares worth $1.57M. The position accounts for 0.55% of the portfolio, ranked #38.

Argentarii first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.13M in Q1 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Argentarii held 25,022 shares of Boston Scientific worth $1.57M as of Q1 2026.
Argentarii sold 3,631 Boston Scientific shares in Q1 2026, an estimated $290K.
Boston Scientific made up 0.55% of Argentarii's portfolio in Q1 2026, its #38 holding.
Argentarii first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Argentarii's Boston Scientific position peaked at $3.13M in Q1 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.